<DOC>
	<DOC>NCT01053481</DOC>
	<brief_summary>The purpose of this study is to determine whether increasing levels of serum 25(OH)Vitamin D as achieved by oral supplementation higher than the current recommendations are associated with a less negative bone calcium balance in post-menopausal Swiss women.</brief_summary>
	<brief_title>Using Ca-41 Methodology to Assess the Impact of Different Vitamin D Supplementation Levels on Postmenopausal Bone Health</brief_title>
	<detailed_description>In a substudy - not related to the vitamin D intervention - spot and 24 h urine samples are compared with regard to the assessment of iodine status in Swiss post-menopausal women. In an short subsequent study using five of the subjects who participated in the original trial, the effect of a 40 d-exercise program (rebounding on a trampoline) on Ca-41 excretion will be observed.</detailed_description>
	<mesh_term>Bone Diseases, Metabolic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>apparently healthy women, at least 5 years postmenopausal BMI 1830 no HRT no regular intake of Ca or vit D supplements wiling and able to give written informed consent and to understand, participate and comply with study requirements nonsmokers no long travels (&gt;3 wk) planned within study period diseases that predispose to osteoporosis history of fragility fractures currently on a weight reduction program excessive physical activity diseases influencing calcium metabolism (thyroid, parathyroid, adrenal disorders etc.) regular intake of medication affecting calcium metabolism osteoporosis (Tscore below 2.5) history of psychological illness likely to interfere with the subject's ability to understand the requirements of the study participation in concurrent studies</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>